Summary
The paper discusses drug discovery strategies for inherited retinal degenerations, focusing on the development of small molecule therapies to treat a broader spectrum of blinding diseases.
Categories
Eye health: The paper discusses inherited retinal degenerations, a group of blinding disorders, and explores drug discovery strategies to treat these conditions.
Pharmacology: The paper discusses the development of small molecule therapies for inherited retinal degenerations.
Genetic Disorders: The paper discusses inherited retinal degenerations, which are caused by genetic mutations.
Author(s)
A Das, Y Imanishi
Publication Year
2022
Number of Citations
2
Related Publications
Eye health
- Phototransduction by retinal ganglion cells that set the circadian clock
- Color appearance models
- Diminished pupillary light reflex at high irradiances in melanopsin-knockout mice
- Strange vision: ganglion cells as circadian photoreceptors
- Genetic reactivation of cone photoreceptors restores visual responses in retinitis pigmentosa
Genetic Disorders
- Genetic reactivation of cone photoreceptors restores visual responses in retinitis pigmentosa
- Molecular genetics of ocular diseases
- The causes of retinal dystrophy and the development of more comprehensive screening approach
- LncRNA-XR_002792574. 1-mediated ceRNA network reveals potential biomarkers in myopia-induced retinal ganglion cell damage
- Roles of PIKfyve in the Retina: A Zebrafish Study